This position will be for the duration of Pharma MX project
Internal Audi...
This position will be for the duration of Pharma MX project
Internal Audit and Investigations Group (IAIG)
The purpose of the Internal Audit and Investigations Group is to provide independent and impartial assurance and advice to improve UNOPS operations. The group reports on the use of resources administered by UNOPS and the effectiveness of internal control systems; and enhances the effectiveness of risk management, control and governance processes. Furthermore, the Internal Audit and Investigations Group leads the Executive Director’s investigations into alleged fraud, corruption, waste of resources, abuse of authority or other misconduct and violations of UNOPS regulations, rules and administrative instructions. Visit the IAIG website for more information (https://www.unops.org/about/governance/accountability/iaig). The Internal Audit and Investigations Group is an innovative and vital part of UNOPS and this is an exciting time to join our growing team!
Specific Project Information (PharmaMX)
In line with the framework agreement signed with the Government of Mexico, UNOPS supports the different collaboration initiatives by the government that are aimed at the fight against corruption and transparency in the public management; as well as in the exercises aimed at strengthening government actions in the areas of acquisitions, infrastructure and management of high impact projects in Mexico.
UNOPS work in Mexico is aligned to the needs of partners which require strategic and operational perspectives, and effective and efficient management of resources to ensure transparency while promoting the continuous development and strengthening of internal processes in order to achieve high-quality results.
The objective of the project is to support the Government of Mexico in its effort to guarantee the right to health to the largest number of inhabitants through the planning and management of the consolidated purchase of medicines (period 2021-2024), as well as assistance in the profiling of the system and model of consolidated purchase of medicines for the health sector of the Government of Mexico.